OneMedNet Corporation (ONMDW)
| Market Cap | 34.39M +166.2% |
| Revenue (ttm) | 1.46M +147.7% |
| Net Income | -8.43M |
| EPS | -0.15 |
| Shares Out | 59.29M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | n/a |
| Previous Close | 0.0349 |
| Day's Range | n/a |
| 52-Week Range | 0.0181 - 0.2420 |
| Beta | 1.16 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 13, 2026 |
About ONMDW
OneMedNet Corporation, a healthcare software company, provides digital medical image management, exchange, and sharing solutions in the Americas, Europe, and the Middle East. It offers iRWD, which provides regulatory grade imaging and clinical data in the pharmaceutical, device manufacturing, contract research organizations, and artificial intelligence markets markets. The company also provides BEAM, a medical imaging exchange platform between hospital/healthcare systems, imaging centers, physicians, and patients. OneMedNet Corporation is headq... [Read more]
News
OneMedNet enters $11.5M pact to supply iRWD platform data
OneMedNet (ONMD) announced it has entered into an agreement to supply its regulatory-grade, multi-modal imaging-centric iRWD platform data for use in the development and training of a foundational AI ...
OneMedNet Secures $11.5+ Million Agreement to Supply Regulatory-Grade Real-World Data for Foundational AI Model Development
MINNEAPOLIS, July 28, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of regulatory decision-grade, AI-driven Real-W...
OneMedNet files to sell 11.68M shares of common stock for holders
17:34 EDT OneMedNet (ONMD) files to sell 11.68M shares of common stock for holders
OneMedNet secures over $3M in new bookings, surpassing full-year 2025
OneMedNet (ONMD) announced it has secured more than $3M in new bookings year-to-date for 2026, surpassing the company’s total bookings for the entire year of 2025. OneMedNet expects to recognize…
OneMedNet Executes on Growth Strategy: Secures Over $3 Million in New Bookings, Surpassing Full-Year 2025
MINNEAPOLIS, June 10, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of regulatory decision-grade, AI-driven Real-W...
OneMedNet Surpasses 90 Million Patient Journeys and 270 Million Studies within its Network
MINNEAPOLIS, June 03, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (the “OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of regulatory decision-grade, AI-Driven Re...
OneMedNet Goes Live with 80 Million Patient Journeys and Billions of Records
MINNEAPOLIS, April 22, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (the “OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of regulatory decision-grade, AI-Driven R...
OneMedNet Announces Strong 2025 Financials and Advances AI-Driven iRWD™ powered by Palantir Foundry enabling Conversational Search on Real-Time Medical Data
OneMedNet Announces Strong 2025 Financials and Advances AI-Driven iRWD™ powered by Palantir Foundry enabling Conversational Search on Real-Time Medical Dat
OneMedNet, Onco-Innovations and Inka Health Announces Collaboration Aimed to Accelerate Potential for Oncology Drug Development Using Real-World Data and AI
OneMedNet, Onco-Innovations and Inka Health Announces Collaboration Aimed to Accelerate Potential for Oncology Drug Development Using Real-World Data and A
OneMedNet announces strategic collaboration with Navidence
OneMedNet (ONMD) announced a strategic collaboration with Navidence to help research organizations transform rapidly expanding healthcare data into clear, actionable real-world evidence. Pharmaceutica...
OneMedNet and Navidence Announce Strategic Collaboration: Empowering Pharma with Precision Real-World Data Insights
MINNEAPOLIS, March 18, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (the “OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of regulatory decision-grade, AI-ready Re...
OneMedNet announces next phase of commercial launch with RWD Platform
OneMedNet (ONMD) Corporation announced the next phase of commercial launch with its RWD Platform powered by Palantir Foundry. Following the November 10, 2025, demonstration of live feeds, subscription...
OneMedNet Announces Next Phase of Commercial Launch with its Real-World Data (RWD) Platform powered by Palantir Foundry
MINNEAPOLIS, Feb. 27, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (the “OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of regulatory-grade, AI-ready Real-World D...
OneMedNet announces strategic partnership with ViuHealth
OneMedNet (ONMD) Corporation announced a strategic partnership with ViuHealth. This partnership expands OneMedNet’s autoimmune clinical ontology, to the OneMedNet iRWD platform. Under the agreement, V...
OneMedNet Partners with ViuHealth to Enhance Autoimmune Dataset Scale, Accelerating Recurring Revenue from Life Sciences and AI Customers
MINNEAPOLIS, Feb. 26, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD), a leading provider of regulatory-grade, AI-ready Real-World Data (RWD), today announced a strategic partnership wit...
OneMedNet enters data licensing agreement with Risorius
OneMedNet (ONMD) Corporation announced a strategic data licensing agreement with Risorius. This new relationship supports OneMedNet’s continued focus on expanding its base of subscription contracts, a...
OneMedNet Announces Strategic Neuro Data Partnership with Risorius to Advance EEG-Based Digital Biomarkers
MINNEAPOLIS, Feb. 24, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD), a leading provider of regulatory-grade, AI-ready Real-World Data (RWD), today announced a strategic data licensing ...
OneMedNet announces total bookings of $2.79M in contract value signed in 2025
“This year represents a strategic inflection point for OneMedNet (ONMD),” said Aaron Green, CEO & President of OneMedNet. “We are increasing bookings and deal size, and we are successfully transitioni...
OneMedNet Reports Record 2025 Bookings of $2.79 Million, Surpassing Prior Year by More Than 4.1X and Accelerating Subscription Transition
MINNEAPOLIS, Feb. 12, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq:ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leader in AI-powered Real-World Data (RWD), today announced reco...
OneMedNet announces data supported FDA 510k clearance of Scaida BrainCT-ICH
OneMedNet (ONMD) announced that its clinical data supported mlHealth 360 in obtaining U.S. Food and Drug Administration, FDA, 510(k) clearance for Scaida BrainCT-ICH. Aaron Green, CEO and President of...
OneMedNet Real-World Data Supports FDA 510(k) Clearance of AI-Powered Scaida BrainCT-ICH Software
MINNEAPOLIS, Jan. 22, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD), a leading provider of regulatory-grade, AI-ready Real-World Data (RWD), today announced that its high-quality, mult...
OneMedNet delivers Real-World Data feed of 1.5M patients
OneMedNet (ONMD) announced that this month it has successfully delivered an anonymized Real-World Data feed representing 1.5 million patients and 4 million encounters to a premier healthcare data and ...
OneMedNet Delivers a Real-World Data feed of 1.5M Patients consisting of 4M encounters
MINNEAPOLIS, Jan. 16, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD), a leading provider of regulatory-grade, AI-ready Real-World Data (RWD), today announced that this month it has succ...
OneMedNet issues letter to shareholders
OneMedNe announced that Aaron Green, President and CEO, issued the following letter to shareholders and other stakeholders of the Company: “2025 has been a year of focus for OneMedNet (ONMD)…
OneMedNet CEO Aaron Green Issues Letter to Shareholders Highlighting 2025
MINNEAPOLIS, Dec. 22, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator and provider of one of the world's largest regulatory-grade, AI-...